Latest Commercialisation News

Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.

Optiscan Imaging Ltd has initiated Australia’s first intra-operative head and neck cancer imaging study using its advanced InVue® and InForm™ devices, aiming to enhance surgical precision and support FDA regulatory submissions.

ABx Group has produced its maiden mixed rare earth carbonate from Tasmania’s Deep Leads deposit, boasting dysprosium and terbium contents far exceeding peers and commanding a premium basket price.

Lindian Resources confirms a high-grade, ultra-low-radiation rare earth carbonate product from its Kangankunde project, achieving 97% recovery of critical neodymium and praseodymium. The breakthrough promises simpler processing and competitive operating costs.

Environmental Clean Technologies Limited has appointed renowned PFAS litigation expert Robert Bilott to its Advisory Board, aiming to accelerate commercialisation of its innovative remediation technology. This strategic move coincides with shareholder approval of ECT’s acquisition of Terrajoule Pty Ltd.

Environmental Clean Technologies (ECT) has taken a major step in tackling the global PFAS contamination crisis by acquiring Rice University’s Flash Joule Heating technology and appointing renowned PFAS attorney Robert Bilott to its advisory board.

Imagion Biosystems is set to submit its Investigational New Drug application for the MagSense® HER2 breast cancer imaging agent in December 2025, paving the way for a Phase 2 clinical trial in early 2026. Collaboration with Wayne State University has refined the trial design, promising improved patient safety and diagnostic precision.

Wide Open Agriculture shakes up its leadership with a new board appointment and plans to recruit a CEO experienced in scaling plant protein businesses, signaling a strategic push to globalise its lupin protein technology.

Bass Oil’s latest Triassic gas study reveals promising new structural features around the Kiwi gas discovery, suggesting a valuable new commercial hub in the northern Cooper Basin.

Control Bionics has secured $3.25 million through a discounted share placement, aiming to boost its assistive and neurotechnology product growth globally.

Brazilian Critical Minerals Ltd has confirmed high-grade rare earth element mineralisation at its Ema project in Brazil, with new drilling results extending the resource footprint and reinforcing the project's economic potential.

Altech Batteries has refreshed its board and launched a strategic reset aimed at accelerating the commercial rollout of its advanced CERENERGY and Silumina Anodes™ battery technologies.